Abstract. Akt/protein kinase B is a downstream target of the phosphatidylinositol 3-kinase (PI3K) pathway and plays a critical role in promotion of cell survival. The function of transcriptional coactivator p300 is required by many transcription factors to either activate or repress gene expression. Here, we show that induction of PI3K enhances the metabolic stability of endogenous p300 protein. On the other hand, repression of PI3K by LY294002 induces p300 degradation through the 26S proteasome CMLS, Cell. Mol. Life Sci. 61 (2004) 
Transcriptional coactivator p300, a histone acetyltransferase, acts in concert with many DNA-binding proteins to facilitate signal-modulated chromatin remodeling and gene expression that control an array of cellular functions, including proliferation and differentiation [1] . Mice lacking both p300 alleles exhibit specific transcriptional defects, poor proliferation and die around midgestation. Interestingly, mice heterozygous for p300 also exhibit retarded growth, heart and brain abnormalities and significant embryonic lethality, underlying the importance of tight regulation of the steady-state level of p300 and its activity during proliferation, development and growth [2] . Many lines of evidence have demonstrated p300 as a transcriptional integrator of multiple signaling pathways [3] [4] [5] . However, very little is known about how the activ-* Corresponding author. ity of p300 itself is regulated in response to internal and external stimuli. Some studies suggest that post-translational modifications, such as phosphorylation and ubiquitination, may play a role in modulating the transcriptional activity of p300 [6] [7] [8] [9] [10] [11] . Recently, Girdwood et al. [12] demonstrated that p300 is modified by the ubiquitinlike protein SUMO, and this modification leads to transcriptional repression of p300, suggesting yet another mechanism for controlling the transcriptional activity of p300. The discoveries of histone deacetylase inhibitors, such as sodium butyrate, have provided powerful tools to study acetylation and transcription. While histone deacetylase inhibitors, generally, enhance gene expression from various promoters [4, 5, 13, 14] , sodium butyrate inhibits the activation of the tyrosine aminotransferase gene and MMTV promoter [15] [16] [17] [18] through stimulating selective p300 degradation [9] . In addition, sodium butyrate and other histone deacetylase inhibitors affect a variety of cellular processes, such as growth, differentiation and apoptosis by mechanisms that are still unknown [19] [20] [21] [22] . Akt, also known as protein kinase B (PKB), is a downstream effector of phosphatidylinositol 3-kinase (PI3K) and has been implicated in several cellular processes including proliferation, growth and metabolism [23] . Three members of the Akt/PKB family have been identified in mammalian cells: Akt1/PKBa, Akt2/PKBb and Akt3/PKBg, which, in general, are widely expressed [23, 24] . They are activated by a variety of stimuli, such as hormones, growth factors and cytokines in a PI3K-dependent manner [25] . A growing body of evidence suggests that Akt has an essential role in promoting cell survival. Dominant negative mutants of Akt reduce the rates of cell survival in granule cells, whereas over-expression of wild-type or constitutively active Akt enhances the rate of cell survival in the absence of growth factors [26] . The ability of constitutively active Akt to inhibit apoptosis induced by UV irradiation, matrix detachment and DNA damage has also been observed in a variety of cell types [27] [28] [29] [30] . Molecular mechanisms by which Akt promote cell survival depend on multiple factors. The function of Akt is mediated through phosphorylation of substrate proteins and the consensus sequence optimal for Akt phosphorylation has been established as RXRXXS/T [31, 32] . Transcriptional coactivator p300 is one of the potential substrates subject to Akt phosphorylation [33, 34] . Studies of the downstream targets of Akt suggest that Akt phosphorylation inhibits directly or indirectly the activity of many pro-apoptotic factors, such as BAD, caspase 9, transcription factors of the forkhead family and p53 [35] [36] [37] [38] [39] . Apart from being a negative regulator of apoptosis, Akt also promotes cell survival by down-regulating the inhibitor of pro-survival pathways. For example, phosphorylation of IkB-kinase (IKK) by Akt induces the proteasome-mediated degradation of inhibitor IkB, which results in the activation of NF-kB, a pro-survival transcription factor [40] [41] [42] . Here, we identify Akt as a positive regulator of p300, whose integrator activity is required for proliferation and growth during development. We show that Akt interacts with the transcriptional integrator p300 and Akt activity is required for sustaining the steady-state level of endogenous p300 protein.
Material and methods

Plasmids and reagents
The expression plasmids for GST-p300 fusion proteins, constitutive active Akt and the bRE3-Luc reporter have been described previously [43] [44] [45] . MG132 was purchased from Sigma. LY294002, MG115, MG101 and lac-1676 J. Chen et al. Regulation of p300 by Akt tacystin were from Calbiochem. Antibodies against p300, RARb, cyclin E, SRC and p53 were acquired from Santa Cruz and antibodies specific for Akt and phospho-Akt were from Cell Signaling.
Cell culture and transfection
Tissue culture cells were maintained in modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS; Hyclone) and were cultured for a minimum of 16 h prior to various treatments. Transient transfections were performed with ExGen 500 using the amount of plasmid DNA indicated in the legends [9] . After transfection, the cells were cultured in DMEM supplemented with 10% FBS for 24 h, then treated with LY294002 (20 µM) and/or TTNPB (1 µM) for the indicated hours. A luciferase assay was performed according to the manufacturer's recommendation (Promega). Luciferase activity was expressed as fold induction (normalized to b-Gal activity) relative to untreated controls. The experiment was repeated three times in triplicate.
Whole-cell extracts and immunoprecipitation
For the preparation of whole-cell extracts, cells were incubated with buffer W containing 50 mM Tris-HCl (pH 7.6), 400 mM NaCl, 10 % glycerol, 0.5 mM DTT, 0.5 mM PMSF and 1% NP-40 at 4°C for 30 min. Lysate was purified by centrifugation at 14,000 g at 4°C for 10 min. Protein concentration was determined using the Bradford assay (Bio-Rad) with bovine serum albumin as standard. For the immunoprecipitation procedure, the NaCl concentration of whole-cell extracts was adjusted to 150 mM and the NP-40 concentration to 0.1%. Extracts were incubated with protein A and the indicated antibodies at 4°C for 2 h. All experiments were carried out at least three times.
Metabolic labeling
Cells were cultured in DMEM supplemented with 10% FBS for 22 h. The medium was then replaced with methionine-free medium and the cells were further cultured for an additional 2 h with 100 µCi/ml of 35 S-methionine and harvested for the preparation of whole-cell extracts. The incorporated radioactivity was measured by scintillation counting of the whole-cell extracts and the rate of protein synthesis was calculated as the measured radioactivity per microgram of protein. The half-life of p300 was determined by the remaining incorporated radioactivity of immunoprecipitated p300 following various hours of chase. The quantification was performed using a PhosphoImager (Molecular Dynamics).
Flow cytometry analysis
Following various treatments, cells were harvested and fixed overnight at -20°C in 70 % ethanol. They were then treated with 50 µg/ml of RNase A and stained with 50 µg/ml of propidium iodide at 37°C for 30 min. DNA contents of the cells were analyzed by a fluorescenceactivated cell sorter (Becton Dickinson) to determine the distribution of cells in different phases of the cell cycle.
Immunofluorescence microscopy Cells were grown on glass coverslips for about 14 h before treatment. The cells were then fixed in 4 % paraformaldehyde, permeabilized in 0.2 % NP-40 and blocked in PBS containing 0.2 % Tween 20 and 10 % nonfat milk [46] . The coverslips were incubated with primary antibody specific for p300 (1:300; Santa Cruz) or Akt (1:200; Cell Signaling), then with rhodamine-conjugated secondary antibody (1:150; Jacksons), mounted in 90 % glycerol and visualized by fluorescence microscopy.
Quantitative RT-PCR
Total RNA from cells was isolated using the RNeasy Mini Kit (Qiagen) and 0.5-1 µg was reverse transcribed with 200 units of Superscript II (Invitrogen) at 42°C for 50 min as recommended (Invitrogen). Quantitative PCR was performed with 1 µl of the resulting cDNA using 2.5 units of Platinum Taq DNA Polymerase (Invitrogen), and p300 primers which amplified the 2931-3037 region of p300 mRNA, resulting in a 130-bp PCR product. To account for cell number variations and RT-PCR variables, 18S RNA Internal Standard (Ambion) was used in the PCR reactions which were amplified in duplicate for 20-30 cycles. The PCR products were then resolved on a 1.5 % agarose gel, stained with Vistra Green (Amersham), detected with the Typhoon 8600 Variable Mode Imager (Molecular Dynamics) and quantified using ImageQuant software (Molecular Dynamics). The ratios of p300 and 18S from treated cells were calculated and compared to that from untreated cells.
Results
Cycloheximide does not reduce the steady-state level of endogenous p300
Sodium butyrate, a histone deacetylase inhibitor [47] , has previously been reported to reduce the abundance of endogenous p300 protein and inhibit steroid-induced transcription that depends on the function of the transcriptional coactivator p300 [9] . The negative effect of sodium butyrate on the abundance of p300 protein may be a secondary result of the expression of certain genes since treatment of cells with histone deacetylase inhibitor renders chromatin structure more accessible for transcriptional activation [48] . To determine whether the downregulation of p300 protein by sodium butyrate requires de novo protein synthesis, we examined the abundance of endogenous p300 protein upon sodium butyrate treatment in the presence of cycloheximide. As shown in figure 1A, treatment of HeLa cells with cycloheximide, a ribotoxin that inhibits ribosome translocation [49] , attenuated the reduction of p300 protein induced by sodium butyrate. However, the level of endogenous p300 protein was still very abundant even after 24 h of treatment with cycloheximide ( fig. 1A ). This was quite surprising, as previous studies have shown that the half-life of endogenous p300 protein is in the range of 9-14 h, depending on the methodology and cell lines employed [10, 50] . We thus conducted several control experiments to verify the efficacy of cycloheximide. First, we examined the abundance of cyclin E protein in response to cycloheximide treatment with the same protocol. Western analysis showed that the levels of cyclin E protein were significantly reduced upon cycloheximide treatment ( fig. 1B) . Second, the efficacy of cycloheximide was confirmed by a metabolic labeling procedure. As shown in figure 1C , general protein synthesis was effectively blocked to about 15 % of controls in the cycloheximide-treated cells. Third, using a pulse-chase protocol, we determined that the apparent half-life of p300 protein in the HeLa cells is about 11 h in the absence of cycloheximide, which is in agreement with previous studies ( fig. 1D ). In addition, as with cycloheximide, treatment of the cells with anisomycin, a ribotoxin that blocks peptidyl transfer [51] , did not significantly reduce much the abundance of p300 protein (data not shown). Taken together, these results indicate that cycloheximide, while inhibits de novo protein synthesis in general, maintains the steady-state level of endogenous p300, possibly through increasing the protein stability of the coactivator. Cycloheximide has been reported to trigger cellular stress and activate the PI3K pathway [52] . We hence wished to explore a possible role of the PI3K pathway in maintaining the activity of transcriptional coactivator p300.
LY294002 stimulates p300 degradation through the 26S proteasome pathway
To study the potential role of PI3K in the regulation of the metabolic stability of endogenous p300, we employed a selective PI3K inhibitor, LY294002 [53] . As shown in figure 2A , the steady-state level of endogenous p300 protein in HeLa cells was reduced significantly following the administration of LY294002 to the culture, and cotreatment of the cells with cycloheximide counteracted negative effects of LY294002 on the abundance of p300 protein ( figure 2A ). In addition, treatment of the cells with wortmannin, another specific PI3K inhibitor [54] likewise resulted in the reduction of the endogenous p300 protein (data not shown). Most interesting, MG132, a peptide aldehyde that reversibly inhibits 26S proteasome activity [55] , prevented the down-regulation of p300 protein by LY294002, implying that the 26S proteasome pathway may be involved in the LY294002-stimulated p300 degradation. To verify the specific activity of the 26S proteasome in the LY294002-induced p300 down-regulation, we also used the most specific proteasome inhibitor, lactacystin, since MG132 can also impede certain lysosomal cysteine proteases and calpain [55] . Western analysis demonstrated that treatment of cells with lactacystin inhibited the LY294002-stimulated p300 degradation, as elicited by MG132 ( fig. 2B ). Furthermore, like MG132, other proteasome inhibitors, such as MG115 and MG101 [55] , all counterbalanced the negative effect of LY294002 on the steady-state level of endogenous p300 protein ( fig. 2C ).
Immunofluorescence microscopy analysis revealed that the p300 stain was reduced upon treatment with LY294002 but not upon that with MG132 ( fig. 2D ). Cell cycle studies showed that the effects of LY294002 and proteasome inhibitor on the abundance of p300 protein were not due to the toxicity of these reagents ( fig. 2D, E) . We concluded that the LY294002-stimulated p300 degradation may be mediated through the 26S proteasome.
PI3K activity is required for maintaining the stability and function of p300
To evaluate whether the negative effect of LY294002 on the steady-state level of p300 protein could also be attained through repression of p300 gene expression, we performed quantitative RT-PCR on p300 transcripts after the LY294002 treatment. As shown in figure 3A , treatment of HeLa cells with LY294002 or MG132 did not affect the relative p300 gene expression, confirming that the down-regulation of p300 protein by LY2940002 was largely mediated through selective p300 degradation. To further verify the specificity of LY294002 in the selective p300 degradation, we examined the metabolic stability of p300 in the presence or absence of LY294002 using a pulse-chase protocol. As shown in figure 3B , the stability of p300 protein was significantly reduced in LY294002-treated cells compared to untreated cells. Together, these data suggest that the PI3K pathway plays a role in maintaining the critical level of p300 protein and may have an impact on p300 function. Next, we wished to assess whether LY294002 also has a negative effect on the transcriptional activity of p300. The function of the coactivator p300 is essential for transcriptional activation mediated by the retinoic acid receptor (RAR) [56, 57] and fibroblasts derived from p300 knockout embryos were deficient in RAR-dependent transcription [2]. We thus assessed the impact of LY294002 on RAR signaling using a retinoic acid-responsive reporter (bRE3-Luc), a synthetic RAR-specific ligand, TTNPB, and a b-galactosidase vector as an internal control. As shown in figure 3C , transfection of the cells with the bRE3-Luc reporter alone results in an about 70-fold increase of TTNPB-induced transcription relative to the untreated control. However, in the presence of LY294002, the RAR-mediated transcription was reduced to about 30-fold. In addition, Western analysis showed that the level of RAR protein was not affected by treatment of the cells with LY294002 ( fig. 3D ). This suggests that the inhibitory effects of LY294002 on the RAR-mediated transcription are achieved through selective p300 degradation, as LY294002 induces p300 degradation ( fig. 2A,  3B ) and the RAR-mediated transcription depends on the activity of p300 [2] .
Akt interacts with the transcriptional coactivator p300
We also wished to determine the molecular mechanisms by which the PI3K pathway regulates the metabolic stability of p300. One major downstream target of PI3K is Akt [58] and protein sequence analysis revealed that p300 contains one putative Akt phosphorylation site (RXRXXS, 1829-1834). Both the synthetic peptide and purified p300 fragment harboring this optimal motif have been shown to be targets for Akt phosphorylation [33, 34] . We therefore focused on whether Akt is the downstream molecule that mediates the effect of the PI3K pathway on p300 activity. First, we assessed the phosphorylation of Akt at Ser473 upon cycloheximide treatment by using a specific phosphor-Akt antibody in the Western analysis, since Akt is activated by phosphorylation at the Ser473 [59] . As shown in figure 4A , the phosphorylation of Akt at Ser-473 was augmented significantly following the administration of cycloheximide to the culture, confirming that the level of activated Akt in the cells was indeed enhanced by the cycloheximide treatment. Next, we examined the association of Akt with p300 in a coimmunoprecipitation protocol. Using immobilized Akt monoclonal antibody to precipitate the endogenous Akt 2 and 3, respectively) . The blot was then stripped and reprobed with antibody specific for RAR receptor.
from the cell lysate and p300 antibody for Western blot analysis, we detected p300 protein in the Akt antibody precipitation but not in the negative control ( fig. 4B ). This suggests that the endogenous p300 protein is able to interact with the endogenous Akt, underlying the physiological relevance of the interaction between p300 and Akt. We also mapped the region of p300 that interacts with Akt using a GST pull-down assay. Different GSTp300 fusion proteins spanning the full-length region of p300 [43] were used in the pull-down experiment to examine their ability to associate with constitutively active Akt [45] transiently expressed in HeLa cells. Western analysis of the bound protein using a specific Akt antibody demonstrated that p300 is able to interact with the constitutively active Akt and the region that does so was mapped mainly to the p300 fragment corresponding to amino acids 1459-1892 containing the Akt phosphorylation site ( fig. 4C ).
Akt activity is required to maintain the protein stability of endogenous p300
To assess whether Akt activity is essential for maintaining the protein stability of endogenous p300, two variants of ovarian cancer cell line A2780S were employed. One is a stable cell line expressing HA-tagged constitutively active Akt2, and the other is a control stable line containing the empty vector. The activity of the constitutively active Akt in the stable cells was verified by Western blot and in vitro kinase analysis [60] . Quantitative RT-PCR analysis of p300 mRNA showed that the relative p300 gene expression was not affected by LY294002 treatment in these two cell lines ( fig. 5A) . A cell cycle study demonstrated that the addition of LY294002 to the control cells resulted in an elevated subG1 peak (18.77%), while LY294002 had a much less pronounced effect on the subG1 peak (8. 5C ). Immunofluorescence microscopy analysis illustrated that p300 was localized in the nucleus in both cell lines with or without the LY294002 treatment, while Akt was detected in both the nuclear and cytoplasmic compartments of the cells ( fig.  5D ). In agreement with the results of Western analysis, the level of p300 stain following LY294002 addition was decreased in the control cells while it was not obviously changed in stable cells expressing the constitutively active Akt ( fig. 5D ). Additionally, the cycloheximide treatment reduced the phosphorylation of Akt in the stable cells expressing the constitutively active Akt, and the abundance of p300 protein was consequently decreased ( fig. 5E ). Taken together, these data suggest that Akt activity is essential for sustaining the metabolic stability of endogenous p300 protein.
Discussion
The major conclusion of this work is that the activity of p300 is regulated by the pro-survival kinase Akt. We showed that p300 interacts with Akt and the Akt activity is essential for maintaining the critical steady-state level and the transcriptional activity of p300 (figs. 4, 5), underlying the intricacy and complexity of the cell signaling pathways in the control of cell survival.
Only recently has Akt been recognized as an important regulator of mammalian cell proliferation and survival. There is strong evidence to support the role of Akt in the anti-apoptotic pathway to promote cell survival [23] . Akt fusion proteins (p300-1: amino acid 1-672; p300-2: 672-1193; p300-3: 1069-1459; p300-4: 1459-1892; p300-5: 1893-2414) and 500 µg of cell lysate from HeLa cells expressing constitutively active Akt was used in each pull down assay. The blot was probed with antibody specific to Akt and GST; 10 % of the cell lysate used in the pull-down assay was included as an input control (lane 6). Shown also is the schematic presentation of different truncated forms of GST-p300 fusion protein used in the pull-down assay.
can also influence the pro-survival pathway through an indirect effect on the pro-survival transcription factor NFkB, which, however, would affect only a specific set of genes that is under the control of NFkB [42] . Our results demonstrate that the transcriptional integrator p300 interacts with Akt and the Akt activity is necessary to maintain the steady-state level of p300 protein (figs. 4, 5). Thus, a transcriptional coactivator, or an integrator, is added to the repertoire of Akt targets, which implies not only a much broader role for Akt in control of gene expression, but also a role for Akt in chromatin remodeling, as p300 is a histone acetyltransferase. Activation of gene expression requires the coordinated action of sequence-specific transcription factors and coactivators to recruit the transcription machinery at target promoters [61] . The function of p300 is required by many transcription factors including some pro-survival or pro-apoptotic factors, such as NFkB, p53 and c-Jun [3] . Direct competition for the limited amount of p300 at the overlapping binding site of p300 has been shown to be the molecular mechanism to synchronize the expression or repression of multiple genes [62] . However, the conventional wisdom that p300 is recruited by the transcription factors to the promoter in order to remodel chromatin structure and to facilitate gene expression presents an active role for p300 as a transcriptional activator, but a passive role as an integrator, as a consequence of competition among the different transcription factors. The association of Akt activity with p300 function rightfully places the integrator p300 at the upstreamed of the signal-modulated survival pathway and sheds new light on the intricacy of cell survival and apoptosis. One good example is the involvement of both Akt and p300 in the regulation of transcriptional activity of the transcription CMLS, Cell. Mol. Life Sci. Vol. 61, 2004 Research Article factors NFkB and p53. Phosphorylation of Mdm2 by Akt stimulates its nuclear translocation, resulting in the destabilization of p53, a pro-apoptotic factor whose function requires p300 [38, 39] . On the other hand, Akt phosphorylation indirectly enhances the activity of NF-kB, a prosurvival factor that also requires the function of p300 [3, 41, 42] . Here we showed that the Akt activity is essential for maintaining the critical concentration of p300 protein ( fig. 5) . Thus, other than at the level of the transcription factors, Akt can also promote cell survival and stifle apoptosis at the level of the transcriptional coactivator, or integrator.
The total gene dosage of p300 is critical for development and cell proliferation [2] and the role of p300 in cell survival is connected with various transcription factors that are either pro-survival or pro-apoptotic [3] . Our study reveals that the PI3K signaling pathway modulates p300 activity and suggests a role for p300 as a transcriptional integrator in cell survival.
